{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:03:57Z","timestamp":1790694237608,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T00:00:00Z","timestamp":1490140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T00:00:00Z","timestamp":1490140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pheochromocytomas and paragangliomas (PPGLs) are rare and frequently heritable neural-crest derived tumours arising from the adrenal medulla or extra-adrenal chromaffin cells respectively. The majority of PPGL tumours are benign and do not recur with distant metastases. However, a sizeable fraction of these tumours secrete vasoactive catecholamines into the circulation causing a variety of symptoms including hypertension, palpitations and diaphoresis. The genetic landscape of PPGL has been well characterized and more than a dozen genes have been described as recurrently mutated. Recent studies of DNA-methylation have revealed distinct clusters of PPGL that share DNA methylation patterns and driver mutations, as well as identified potential biomarkers for malignancy. However, these findings have not been adequately validated in independent cohorts. In this study we use an array-based genome-wide approach to study the methylome of 39 PPGL and 4 normal adrenal medullae. We identified two distinct clusters of tumours characterized by different methylation patterns and different driver mutations. Moreover, we identify genes that are differentially methylated between tumour subcategories, and between tumours and normal tissue.<\/jats:p>","DOI":"10.1038\/srep44943","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T11:27:16Z","timestamp":1490182036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations"],"prefix":"10.1038","volume":"7","author":[{"given":"Samuel","family":"Backman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajani","family":"Maharjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Falk-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Crona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenko","family":"Cupisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"St\u00e5lberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Bj\u00f6rklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,22]]},"reference":[{"key":"BFsrep44943_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.0954-6820.1986.tb02755.x","volume":"3","author":"G Stenstr\u00f6m","year":"1986","unstructured":"Stenstr\u00f6m, G. & Sv\u00e4rdsudd, K. Pheochromocytoma in Sweden 1958\u20131981. An analysis of the National Cancer Registry Data. Acta Med. Scand. 3, 225\u2013232 (1986).","journal-title":"Acta Med. Scand"},{"key":"BFsrep44943_CR2","first-page":"802","volume":"12","author":"C Beard","year":"1983","unstructured":"Beard, C., Sheps, S., Kurland, L., Carney, J. & Lie, J. Occurence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin. Proc. 12, 802\u2013804 (1983).","journal-title":"Mayo Clin. Proc."},{"key":"BFsrep44943_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrendo.2014.188","volume":"11","author":"J Favier","year":"2015","unstructured":"Favier, J., Amar, L. & Gimenez-Roqueplo, A.-P. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nature Reviews Endocrinology 11, 101\u2013111 (2015).","journal-title":"Nature Reviews Endocrinology"},{"key":"BFsrep44943_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1056\/NEJMoa1205119","volume":"367","author":"Z Zhuang","year":"2012","unstructured":"Zhuang, Z. et al. Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia. New England Journal of Medicine 367, 922\u2013930 (2012).","journal-title":"New England Journal of Medicine"},{"key":"BFsrep44943_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ng.533","volume":"42","author":"Y Qin","year":"2010","unstructured":"Qin, Y. et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nature genetics 42, 229\u2013233 (2010).","journal-title":"Nature genetics"},{"key":"BFsrep44943_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ng.861","volume":"43","author":"I Comino-M\u00e9ndez","year":"2011","unstructured":"Comino-M\u00e9ndez, I. et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nature genetics 43, 663\u2013667 (2011).","journal-title":"Nature genetics"},{"key":"BFsrep44943_CR7","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1093\/hmg\/dds374","volume":"21","author":"N Burnichon","year":"2012","unstructured":"Burnichon, N. et al. Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma. Human Molecular Genetics 21, 5397\u20135405 (2012).","journal-title":"Human Molecular Genetics"},{"key":"BFsrep44943_CR8","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1210\/jc.2014-1659","volume":"99","author":"G Clark","year":"2014","unstructured":"Clark, G. et al. Germline FH Mutations Presenting With Pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 99, E2046\u2013E2050 (2014).","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"BFsrep44943_CR9","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","volume":"19","author":"N Burnichon","year":"2010","unstructured":"Burnichon, N. et al. SDHA is a tumor suppressor gene causing paraganglioma. Human molecular genetics 19, 3011\u20133020, doi: 10.1093\/hmg\/ddq206 (2010).","journal-title":"Human molecular genetics"},{"key":"BFsrep44943_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/321282","volume":"69","author":"D Astuti","year":"2001","unstructured":"Astuti, D. et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. American journal of human genetics 69, 49\u201354, doi: 10.1086\/321282 (2001).","journal-title":"American journal of human genetics"},{"key":"BFsrep44943_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/81551","volume":"26","author":"S Niemann","year":"2000","unstructured":"Niemann, S. & Muller, U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nature genetics 26, 268\u2013270, doi: 10.1038\/81551 (2000).","journal-title":"Nature genetics"},{"key":"BFsrep44943_CR12","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.287.5454.848","volume":"287","author":"BE Baysal","year":"2000","unstructured":"Baysal, B. E. et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848\u2013851 (2000).","journal-title":"Science"},{"key":"BFsrep44943_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1470-2045(10)70007-3","volume":"11","author":"JP Bayley","year":"2010","unstructured":"Bayley, J. P. et al. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. The Lancet. Oncology 11, 366\u2013372, doi: 10.1016\/S1470-2045(10)70007-3 (2010).","journal-title":"The Lancet. Oncology"},{"key":"BFsrep44943_CR14","doi-asserted-by":"crossref","unstructured":"Cascon, A. et al. Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene. J Natl Cancer Inst. 107 (2015).","DOI":"10.1093\/jnci\/djv053"},{"key":"BFsrep44943_CR15","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1210\/jc.2012-4257","volume":"7","author":"J Crona","year":"2013","unstructured":"Crona, J. et al. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing. Journal of Clinical Endocrinology and Metabolism 7, 1266\u20131271 (2013).","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"BFsrep44943_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/gcc.22267","volume":"54","author":"CC Juhlin","year":"2015","unstructured":"Juhlin, C. C. et al. Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene. Genes, chromosomes & cancer 54, 542\u2013554, doi: 10.1002\/gcc.22267 (2015).","journal-title":"Genes, chromosomes & cancer"},{"key":"BFsrep44943_CR17","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1038\/ncomms7140","volume":"6","author":"L Fishbein","year":"2015","unstructured":"Fishbein, L. et al. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nature communications 6, 6140, doi: 10.1038\/ncomms7140 (2015).","journal-title":"Nature communications"},{"key":"BFsrep44943_CR18","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","volume":"20","author":"N Burnichon","year":"2011","unstructured":"Burnichon, N. et al. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Human Molecular Genetics 20, 3974\u20133985 (2011).","journal-title":"Human Molecular Genetics"},{"key":"BFsrep44943_CR19","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1200\/JCO.2004.05.061","volume":"22","author":"W Kim","year":"2004","unstructured":"Kim, W. & Kaelin, W. Role of VHL Gene Mutation in Human Cancer. Journal of Clinical Oncology 22, 4991\u20135004 (2004).","journal-title":"Journal of Clinical Oncology"},{"key":"BFsrep44943_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","volume":"7","author":"M Selak","year":"2005","unstructured":"Selak, M. et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-\u03b1 prolyl hydroxylase. Cancer Cell 7, 77\u201385 (2005).","journal-title":"Cancer Cell"},{"key":"BFsrep44943_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PLM Dahlia","year":"2014","unstructured":"Dahlia, P. L. M. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nature Reviews Cancer 14, 108\u2013119 (2014).","journal-title":"Nature Reviews Cancer"},{"issue":"10","key":"BFsrep44943_CR22","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1210\/jc.2007-0709","volume":"92","author":"Laurence Amar","year":"2007","unstructured":"Amar, L. et al. Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas. Journal of Clinical Endocrinology and Metabolism 92 (2007).","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"BFsrep44943_CR23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","volume":"128","author":"P Jones","year":"2007","unstructured":"Jones, P. & Baylin, S. The Epigenomics of Cancer. Cell 128, 683\u2013692 (2007).","journal-title":"Cell"},{"key":"BFsrep44943_CR24","doi-asserted-by":"publisher","first-page":"E174","DOI":"10.1210\/jc.2012-2993","volume":"98","author":"O *Barreau","year":"2012","unstructured":"*Barreau, O. et al. Identification of CpG Island Methylator Phenotype in Adrenocortical Carcinomas. Journal of Clinical Endocrinology and Metabolism 98, E174\u2013E184 (2012).","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"BFsrep44943_CR25","doi-asserted-by":"publisher","first-page":"8681","DOI":"10.1073\/pnas.96.15.8681","volume":"96","author":"M Toyota","year":"1999","unstructured":"Toyota, M. et al. CpG island methylator phenotype in colorectal cancer. Proceedings of the National Academy of Sciences 96, 8681\u20138686 (1999).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"BFsrep44943_CR26","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","volume":"17","author":"H Noushmehr","year":"2010","unstructured":"Noushmehr, H. et al. Identification of CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma. Cancer Cell 17, 510\u2013522 (2010).","journal-title":"Cancer Cell"},{"key":"BFsrep44943_CR27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"M Hegi","year":"2005","unstructured":"Hegi, M. et al. MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma. New England Journal of Medicine 352, 997\u20131003 (2005).","journal-title":"New England Journal of Medicine"},{"key":"BFsrep44943_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1677\/ERC-06-0031","volume":"14","author":"J Geli","year":"2007","unstructured":"Geli, J. et al. The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma. Endocrine-related cancer 14, 125\u2013134 (2007).","journal-title":"Endocrine-related cancer"},{"key":"BFsrep44943_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3727\/105221608786883825","volume":"14","author":"P Muscarella","year":"2008","unstructured":"Muscarella, P. et al. Expression of the p16INK4A\/Cdkn2a gene is prevalently downregulated in human pheochromocytoma tumor specimens. Gene Expr 14, 207\u2013216 (2008).","journal-title":"Gene Expr"},{"key":"BFsrep44943_CR30","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1158\/1078-0432.CCR-14-2804","volume":"21","author":"AA de Cubas","year":"2015","unstructured":"de Cubas, A. A. et al. DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers. Clinical cancer research: an official journal of the American Association for Cancer Research 21, 3020\u20133030, doi: 10.1158\/1078-0432.CCR-14-2804 (2015).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"BFsrep44943_CR31","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ccr.2013.04.018","volume":"23","author":"E Letouz\u00e9","year":"2013","unstructured":"Letouz\u00e9, E. et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell 23, 749\u2013752 (2013).","journal-title":"Cancer Cell"},{"key":"BFsrep44943_CR32","doi-asserted-by":"publisher","first-page":"e24967","DOI":"10.1371\/journal.pone.0024967","volume":"6","author":"J Wang","year":"2011","unstructured":"Wang, J., Chen, L., Li, Y. & Guan, X. Y. Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. PloS one 6, e24967, doi: 10.1371\/journal.pone.0024967 (2011).","journal-title":"PloS one"},{"key":"BFsrep44943_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3892\/ol.2013.1736","volume":"7","author":"Q Liu","year":"2014","unstructured":"Liu, Q., Zhang, C., Ma, G. & Zhang, Q. Expression of SPRR3 is associated with tumor cell proliferation and invasion in glioblastoma multiforme. Oncology Letters 7, 427\u2013432 (2014).","journal-title":"Oncology Letters"},{"key":"BFsrep44943_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2119\/molmed.2009.00187","volume":"16","author":"D Cho","year":"2010","unstructured":"Cho, D. et al. Upregulation of SPRR3 promotes colorectal tumorigenesis. Molecular Medicine 16, 271\u2013277 (2010).","journal-title":"Molecular Medicine"},{"key":"BFsrep44943_CR35","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.celrep.2014.06.053","volume":"8","author":"D Brocks","year":"2014","unstructured":"Brocks, D. et al. Intratumour DNA methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer. Cell Repots 8, 798\u2013806 (2014).","journal-title":"Cell Repots"},{"key":"BFsrep44943_CR36","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1158\/1078-0432.CCR-14-2854","volume":"21","author":"J Crona","year":"2015","unstructured":"Crona, J. et al. Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis. Clinical cancer research: an official journal of the American Association for Cancer Research 21, 4451\u20134460, doi: 10.1158\/1078-0432.CCR-14-2854 (2015).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"BFsrep44943_CR37","doi-asserted-by":"publisher","first-page":"e86756","DOI":"10.1371\/journal.pone.0086756","volume":"9","author":"J Crona","year":"2014","unstructured":"Crona, J. et al. Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours. PloS one 9, e86756, doi: 10.1371\/journal.pone.0086756 (2014).","journal-title":"PloS one"},{"key":"BFsrep44943_CR38","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.1073\/pnas.1009843107","volume":"107","author":"P Van Loo","year":"2010","unstructured":"Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proceedings of the National Academy of Sciences of the United States of America 107, 16910\u201316915, doi: 10.1073\/pnas.1009843107 (2010).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep44943_CR39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc B Met 57, 289\u2013300 (1995).","journal-title":"J Roy Stat Soc B Met"},{"key":"BFsrep44943_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/0306-9877(95)90228-7","volume":"45","author":"Y Klipper-Aurbach","year":"1995","unstructured":"Klipper-Aurbach, Y. et al. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 45, 486\u2013490 (1995).","journal-title":"Med Hypotheses"},{"key":"BFsrep44943_CR41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/sim.4780090710","volume":"9","author":"Y Hochberg","year":"1990","unstructured":"Hochberg, Y. & Benjamini, Y. More powerful procedures for multiple significance testing. Stat Med 9, 811\u2013818 (1990).","journal-title":"Stat Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep44943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep44943","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep44943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T05:13:09Z","timestamp":1719119589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep44943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,7,13]]}},"alternative-id":["BFsrep44943"],"URL":"https:\/\/doi.org\/10.1038\/srep44943","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,22]]},"assertion":[{"value":"11 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44943"}}